112 related articles for article (PubMed ID: 215562)
1. Correlated expression of a B-lymphocyte-specific glycoprotein (gp27/35) and the EBV receptor/C3 receptor complex in sublines from the same Burkitt lymphoma.
Klein G; Hyman R; Trowbridge I
Int J Cancer; 1979 Jan; 23(1):37-41. PubMed ID: 215562
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma.
Klein G; Yefenof E; Falk K; Westman A
Int J Cancer; 1978 May; 21(5):552-60. PubMed ID: 207646
[TBL] [Abstract][Full Text] [Related]
3. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.
Kurakata S; Ramos OF; Klein G; Klein E
Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147
[TBL] [Abstract][Full Text] [Related]
4. Studies on the B lymphoblast antigen No. 1 (BB-1) on a series of Burkitt lymphoma lines differing in the expression of the EBV/C3 receptor complex.
Ehlin-Henriksson B; Clark EA; Jønsson V; Klein G
J Immunol; 1983 May; 130(5):2448-52. PubMed ID: 6187858
[TBL] [Abstract][Full Text] [Related]
5. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
6. Fc and C3 receptor patterns on two EBV- negative Burkitt lymphoma lines during acute exposure to EBV (P3HR-1 substrain).
Jønsson V; Klein G
Eur J Cancer (1965); 1981 Feb; 17(2):161-5. PubMed ID: 6266834
[No Abstract] [Full Text] [Related]
7. Activation and fixation of C3 by human B cell lines is enhanced by interferon-gamma and tumor necrosis factor alpha.
Yefenof E; Algarra I; Ramos OF; Klein E
Complement Inflamm; 1991; 8(5-6):271-80. PubMed ID: 1666351
[TBL] [Abstract][Full Text] [Related]
8. Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma lines.
Yefenof E; Klein G
Int J Cancer; 1977 Sep; 20(3):347-52. PubMed ID: 198382
[TBL] [Abstract][Full Text] [Related]
9. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
[TBL] [Abstract][Full Text] [Related]
10. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line,
Dalianis T; Klein G; Andersson B
Int J Cancer; 1977 Apr; 19(4):460-7. PubMed ID: 191413
[TBL] [Abstract][Full Text] [Related]
11. Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and Epstein-Barr virus (EBV)-positive and -negative B lymphoid cell lines.
Nilsson K; Andersson LC; Gahmberg CG; Wigzell H
Int J Cancer; 1977 Nov; 20(5):708-16. PubMed ID: 200571
[No Abstract] [Full Text] [Related]
12. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
[TBL] [Abstract][Full Text] [Related]
13. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus receptor is distinct from the C3 receptor.
Wells A; Koide N; Stein H; Gerdes J; Klein G
J Gen Virol; 1983 Feb; 64 (Pt 2)():449-53. PubMed ID: 6300295
[TBL] [Abstract][Full Text] [Related]
15. Quantitative comparison of Epstein-Barr virus receptor expression on sIgM and sIgG cell lines and B-cell lymphoma biopsies.
Wells A; Godal T; Kvaløy S; Steen HB; Klein G
Differentiation; 1982; 22(2):113-9. PubMed ID: 6290303
[TBL] [Abstract][Full Text] [Related]
16. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.
McConnell I; Klein G; Lint TF; Lachmann PJ
Eur J Immunol; 1978 Jul; 8(7):453-8. PubMed ID: 211040
[TBL] [Abstract][Full Text] [Related]
17. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.
Sairenji T; Hinuma Y
Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
[TBL] [Abstract][Full Text] [Related]
19. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
